“COMPARATIVE ASSESSMENT OF GEFITINIB AND ERLOTINIB THERAPY IN SUBJECTS WITH NON-SMALL CELL LUNG CARCINOMA”. 2023. International Research Journal of Pharmacy 14 (9): 1-5. https://irjponline.org/index.php/irjp/article/view/64.